Navigation Links
CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
Date:10/6/2009

SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- CareFusion (NYSE: CFN), a new clinical and medical products corporation, has received No. 1 rankings by independent market research firms for two of the corporation's key brands. CareFusion's Pyxis® technologies were again named number one in user satisfaction ratings in MD Buyline's 2009 third quarter report (July through September) for the third consecutive quarter; and CareFusion's MedMined(TM) Services received the annual top ranking for infection surveillance technology providers by KLAS, published in August 2009.

"These rankings reflect our commitment to deliver superior customer service and innovative medical technologies that are clinically proven to improve patient care," said Dave Schlotterbeck, chairman and chief executive officer of CareFusion. "While CareFusion is a new company, we have a long history of helping hospitals and medical facilities improve health care delivery in terms of effectiveness, cost efficiencies and, most importantly, patient safety."

MD Buyline collects technology evaluations from health care providers and tallies the scores based on a 12-month rolling average score. KLAS' ratings are based on the overall performance calculated from individual scores for each of 40 criteria, consisting of 28 performance indicators and 12 business indicators based on a 100-point scale.

CareFusion's Pyxis® technologies for managing medications and supplies have been shown to reduce supply costs by 50 percent(1) and help to protect 1.5 million patients annually from medication errors(2). Additionally, CareFusion estimates that its MedMined(TM) Services has the potential to help hospitals save 6,800 lives and $1 billion in health care costs annually by helping to identify at-risk patients and ways to reduce health care-acquired infections (HAIs)(3).

Pyxis® Technologies will be highlighted at the upcoming Managing Today's OR Suite (MTORS) Conference and Exhibition in Las Vegas, Nev., from October 7-8, 2009.

About the MD Buyline and KLAS Rankings

MD Buyline provides the most comprehensive database of information on health care products. MD Buyline members use the data to make informed decisions, which enables cost savings and operational efficiencies.

KLAS is a research firm specializing in monitoring and reporting the performance of health care vendors. KLAS' mission is to improve delivery of care, by independently measuring vendor performance for the benefit of health care providers, consultants, investors, and vendors. The 2009 KLAS report, Infection Control: Improving Patient Care and Reimbursements, highlights the recent growth and leading vendors in the market for infection control software, which analyzes data from various hospital departments to identify potential infections.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

    (1) St. John's Medical Center. CareFusion, 2007.
    (2) Preventing Medication Errors: Quality Chasm Series. Institute of
        Medicine, July 2006.
    (3) Projection based on aggregate internal analysis of 174 MedMined
        services clients' performance between August 2006 and October 2008.

SOURCE CareFusion Corporation


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Fals-Stewart Earns Hazeldens 2007 Dan Anderson Research Award
2. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
5. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
6. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
7. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
8. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
9. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
10. Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients
11. Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... 30, 2017 In vitro diagnostics market firm ... May, at least ten diagnostic companies have successfully completed ... offerings and a loan facility.  The size of these ... million.  Kalorama Information provides a monthly IVD Market ... Knowledge Center. ...
(Date:6/30/2017)... POINT, N.C. , June 29, 2017  Axium Pharmaceuticals Inc. ... for developing improved novel formulations and alternative dosage forms of ... ... delivery is based on our waterless self-nano emulsifying formula, which ... contact with saliva. We believe the spray will provide fast ...
Breaking Medicine Technology:
(Date:7/23/2017)... ... July 23, 2017 , ... The ... and training standards for healthcare treatment providers, offers healthcare professionals a unique ... Core Curriculum. , Presented as either online or as a 2-day, pre-symposium ...
(Date:7/23/2017)... ... July 23, 2017 , ... Technology is making it ... relationships. New tools are helping patients become more actively involved in their care ... Most Wired® survey, released today by the American Hospital Association’s (AHA) Health Forum. ...
(Date:7/22/2017)... ... July 21, 2017 , ... Reassured For Life ( http://www.reassured.ca ... servicing Albertans,” says owner and licensed broker Nerissa McNaughton. “I launched this firm because ... but it is a very necessary conversation. I make it easy. As a broker ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... consultations to communities in the greater Denver region, is announcing a charity drive ... a very rare kind of epilepsy. , Until a few months ago, Dominik ...
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the ... solution for colleges and universities at the APPA 2017 Annual Conference and ... and tobacco smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke ...
Breaking Medicine News(10 mins):